颈内动脉灌注治疗恶性脑瘤的研究进展
摘要
恶性胶质瘤和脑转移瘤预后极差,手术切除后辅以放疗和化疗可适当延长病人的存活时间。常规的全身化疗因严重的全身毒副作用以及血脑屏障(BloodBrain Barrier,BBB)阻碍药物向瘤实质渗透,使化疗对大多数脑瘤作用有限。对此。
出处
《广东医学》
CAS
CSCD
1996年第2期122-123,共2页
Guangdong Medical Journal
参考文献3
-
1Koichi Ichimura,Kikuo Ohno,Masaru Aoyagi,Masashi Tamaki,Ryuta Suzuki,Kimiyoshi Hirakawa. Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery[J] 1993,Journal of Neuro - Oncology(3):211~215
-
2Akira Hodozuka,Kazuhiro Sako,Hirofumi Nakai,Masayuki Tomabechi,Nozomi Suzuki,Yukichi Yonemasu. Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats[J] 1993,Journal of Neuro - Oncology(1):79~86
-
3Walter W. Eckman,Clifford S. Patlak,Joseph D. Fenstermacher. A critical evaluation of the principles governing the advantages of intra-arterial infusions[J] 1974,Journal of Pharmacokinetics and Biopharmaceutics(3):257~285
-
1邓跃飞,钟志光,林吉惠,谭平国.卡铂和鬼臼噻吩甙联合颈内动脉灌注治疗脑恶性胶质瘤[J].中国神经精神疾病杂志,1999,25(4):247-247. 被引量:1
-
2陈志平,菅树声,李文良,张继伟.颈内动脉灌注ACNU治疗脑恶性肿瘤(附24例报告)[J].实用肿瘤学杂志,1998,12(1):32-33. 被引量:2
-
3郑佳坤,文锡荣,林小聪,林剑雄,王永惜.顺铂与卡氮介颈内动脉灌注治疗颅内恶性肿瘤(附60例报告)[J].实用肿瘤杂志,1996,11(6):284-285.